Brentuximab 是靶向CD30的嵌合抗体。Brentuximab 可用于新兴靶向疗法的研究。
| 生物活性 | Brentuximab is a chimeric antibody targetingCD30. Brentuximab can be used for the research of emerging targeted therapies[1]. |
| IC50& Target | |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com